13F

Stock

Estrella Immunopharma Inc

Ticker not mapped · held by 16 managers

Reported value

$5.49M

Holders

16

+6 new · −6 exited

Holders’ est. mark

−$135.6K

Price effect on 8 books still in the name

Largest holder

$4.34M

ARMISTICE CAPITAL, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC4.1M$4.34MNew
VANGUARD CAPITAL MANAGEMENT LLC382.5K$405.4KHeld
WELLS FARGO & COMPANY/MN264.4K$280.3KNew
GEODE CAPITAL MANAGEMENT, LLC157.5K$166.9K−$54.9KCut−$4.37K
VANGUARD FIDUCIARY TRUST CO64.9K$68.8KHeld
Renaissance Technologies62.8K$66.6K−$31.4KCut−$124.5K
State Street43.3K$45.8K−$21.6KCut−$21.6K
BlackRock, Inc.39.9K$42.3K−$13.2KAdded$990
NORTHERN TRUST CORP19.6K$20.8K−$9.81KCut−$9.81K
US BANCORP \DE\16.9K$17.9KNew
UBS Group AG15.1K$16K−$1.59KAdded$11K
ROYAL BANK OF CANADA6.6K$7K−$3KCut−$3K
Tower Research Capital LLC (TRC)4.86K$5.15KNew
TORONTO DOMINION BANK1.09K$1.15KNew
WOLVERINE ASSET MANAGEMENT LLC468$496New
MORGAN STANLEY1$1−$1Cut−$17.3K

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.